Company / Operating Income per Share
Cytek Biosciences, Inc. Operating Income per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.31
FY2025
5-year range
-$0.31 / $0.44
FY2021-FY2025
Trend
-97.8%
vs FY2024
Sector context
#110 of 154
Health Care
What the data says
At $-0.31, Cytek Biosciences, Inc.'s operating income per share ranks #110 of 154 in the Health Care sector. Operating Income per Share has fluctuated over the past 6 years, ranging from $-0.31 in FY2025 to $0.44 in FY2021.
Based on SEC 10-K filings.
-0.31 in FY2025.
Declined from $-0.21 to $-0.31 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#110 of 154 in Health CareTop 71% of 154This company -$0.31 Sector average $4.29
▼
-107.3% below sector average
Key checks
Key Insights
- In FY2025, operating income per share decreased 97.8% year-over-year.
- Ranks #110 out of 154 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.31 | -97.8% |
| FY2024 | -$0.16 | +25.4% |
| FY2023 | -$0.21 | -1479.3% |
| FY2022 | -$0.01 | -103.1% |
| FY2021 | $0.44 | +4.3% |
| FY2020 | $0.42 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026